- Home
- MYGN vs TITN Comparison
MYGN vs TITN Comparison
Compare MYGN & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- TITN
- Stock Information
- Founded
- MYGN 1991
- TITN 1980
- Country
- MYGN United States
- TITN United States
- Employees
- MYGN N/A
- TITN N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TITN Other Specialty Stores
- Sector
- MYGN Health Care
- TITN Consumer Discretionary
- Exchange
- MYGN Nasdaq
- TITN Nasdaq
- Market Cap
- MYGN 423.1M
- TITN 341.6M
- IPO Year
- MYGN 1995
- TITN 2007
- Fundamental
- Price
- MYGN $6.02
- TITN $20.58
- Analyst Decision
- MYGN Hold
- TITN Buy
- Analyst Count
- MYGN 13
- TITN 5
- Target Price
- MYGN $13.50
- TITN $21.00
- AVG Volume (30 Days)
- MYGN 2.4M
- TITN 120.1K
- Earning Date
- MYGN 08-05-2025
- TITN 08-28-2025
- Dividend Yield
- MYGN N/A
- TITN N/A
- EPS Growth
- MYGN N/A
- TITN N/A
- EPS
- MYGN N/A
- TITN N/A
- Revenue
- MYGN $832,900,000.00
- TITN $2,667,755,000.00
- Revenue This Year
- MYGN N/A
- TITN N/A
- Revenue Next Year
- MYGN $6.64
- TITN $0.57
- P/E Ratio
- MYGN N/A
- TITN N/A
- Revenue Growth
- MYGN 3.83
- TITN N/A
- 52 Week Low
- MYGN $3.76
- TITN $12.50
- 52 Week High
- MYGN $29.30
- TITN $23.41
- Technical
- Relative Strength Index (RSI)
- MYGN 62.34
- TITN 59.65
- Support Level
- MYGN $5.23
- TITN $19.11
- Resistance Level
- MYGN $6.07
- TITN $20.13
- Average True Range (ATR)
- MYGN 0.39
- TITN 0.61
- MACD
- MYGN 0.05
- TITN 0.09
- Stochastic Oscillator
- MYGN 81.27
- TITN 88.73
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.